Back
Full-text
Journal article

Islet inflammation in type 2 diabetes.

  • Böni-Schnetzler M Endocrinology, Diabetes and Metabolism, University Hospital of Basel, 4031, Basel, Switzerland. marianne.boeni@unibas.ch.
  • Meier DT Endocrinology, Diabetes and Metabolism, University Hospital of Basel, 4031, Basel, Switzerland.
  • 2019-04-17
Published in:
  • Seminars in immunopathology. - 2019
Cytokines
IL-1β
Insulin
Islet inflammation
Type 2 diabetes
β-Cell
Cytokines
Diabetes Mellitus, Type 2
Humans
Inflammation
Insulin-Secreting Cells
Signal Transduction
English Metabolic diseases including type 2 diabetes are associated with meta-inflammation. β-Cell failure is a major component of the pathogenesis of type 2 diabetes. It is now well established that increased numbers of innate immune cells, cytokines, and chemokines have detrimental effects on islets in these chronic conditions. Recently, evidence emerged which points to initially adaptive and restorative functions of inflammatory factors and immune cells in metabolism. In the following review, we provide an overview on the features of islet inflammation in diabetes and models of prediabetes. We separately emphasize what is known on islet inflammation in humans and focus on in vivo animal models and how they are used to elucidate mechanistic aspects of islet inflammation. Further, we discuss the recently emerging physiologic signaling role of cytokines during adaptation and normal function of islet cells.
Language
  • English
Open access status
hybrid
Identifiers
Persistent URL
https://sonar.ch/global/documents/92253
Statistics
Document views: 12 File downloads:
  • fulltext.pdf: 0